Eltrombopag Phase III Study In Chinese Chronic ITP Patients

NCT01762761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic and Hepatitis C

Interventions

DRUG: eltrombopag
DRUG: placebo

Sponsor

Novartis Pharmaceuticals